The efficacy of watch and wait strategy or surgery after neoadjuvant immunotherapy for locally advanced colorectal cancer with dMMR/MSI-H guided by ctDNA dynamic monitoring (WINDOW): A single-center, ...
Among patients with high-risk malignant colorectal polyps, 19% had residual disease, with rates of 25% in the immediate surgery group vs 9% in the nonoperative management group. The rate of rectum and ...
Morning Overview on MSN
A colon cancer therapy shrank tumors so well that most patients showed no cancer before surgery
A short course of immunotherapy given before surgery eliminated detectable colon cancer in a majority of patients whose tumors lacked a key DNA repair mechanism, according to results published in the ...
Commonwealth Health Physician Network announced William Auriemma, M.D. — a member of the medical staff at Regional Hospital of Scranton — joined its provider team and is now accepting new patients in ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results